Freenome

South San Francisco

Freenome is a biotechnology company driven to provide the tools needed to detect, treat and prevent cancer using routing blood draw. This company was founded in 2014 by Gabe Otte, Riley Ennis, Charles Roberts and is headquartered in South San Francisco, CA. Freenome combines molecular biology with advanced computational biology and machine learning to help with early cancer detection.

Freenome's valuation today

Estimated valuation today

$157M

-94.29% since last round

Calculated based on estimated multiplier and revenue.

Estimated multiplier for Freenome

2.46x revenue

Calculated based on public comps and hype multiple.

Revenue

Update this based on your knowledge or projections. Calculations use last 12 months revenue.

million

Hype Multiple

Currently selected comps have a median growth rate of 11.40%

This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.

multiple

Shares are worthless

In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.

Last round

The last round was 8 months ago.

Date

December 2021

Valuation

$2.7B

Amount raised

$290M

Public market comparisons

We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.

Multiple at last round

1.70x revenue

Today's multiple

1.64x revenue

Change

-3.70%

Companies

Industry – Healthcare

Last updated 5 mins ago.

RemoveNameTicker Price multiple
Freenome

1.64x
1Life Healthcare Inc

ONEM

4.38x
HCA Holdings Inc

HCA

1.04x
Tenet Healthcare Corporation

THC

0.37x
Quest Diagnostics Incorporated

DGX

1.51x
Humana Inc

HUM

0.67x
Valuation history
Fundraising rounds
DateRound Amount raised
Price per share (Preferred)
Valuation
Dec 2021Series E$290MM$11.67$2.74B
Dec 2021Series D$300MM$7.54$1.43B
Aug 2020Series C$270MM$6.61$927.08MM
Jul 2019Series B$165MM$4.56$464.3MM
Aug 2017Series A$69.62MM$3.07$196.16MM
Jun 2016Series Seed-2$5.55MM$0.61$25.34MM
May 2016Series Seed-1$800.02K$0.24$2.67MM
Related companies

With a revenue of $64M and a Hype Multiple of 1.5x,
Freenome is estimated to be worth $157M.